Literature DB >> 28891147

Commentary on Pardo (2017) and Moyo et al. (2017): Much still unknown about prescription drug monitoring programs.

Corey S Davis1,2.   

Abstract

Keywords:  Addiction; law; opioids; overdose; policy; prescription drug monitoring programs

Mesh:

Substances:

Year:  2017        PMID: 28891147     DOI: 10.1111/add.13936

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  3 in total

1.  Where Next for Opioids and the Law? Despair, Harm Reduction, Lawsuits, and Regulatory Reform.

Authors:  Scott Burris
Journal:  Public Health Rep       Date:  2017-12-13       Impact factor: 2.792

2.  Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.

Authors:  Patience Moyo; Linda Simoni-Wastila; Beth Ann Griffin; Donna Harrington; G Caleb Alexander; Francis Palumbo; Eberechukwu Onukwugha
Journal:  Health Serv Res       Date:  2019-08-02       Impact factor: 3.402

3.  The importance of data source in prescription drug monitoring program research.

Authors:  Jill R Horwitz; Corey Davis; Lynn McClelland; Rebecca Fordon; Ellen Meara
Journal:  Health Serv Res       Date:  2020-09-02       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.